BRCA2 and prostate carcinoma: This similar SIR implies a surveillance bias, but an increased risk of poorly differentiated prostate cancer and prostate cancer-specific death in BRCA2, 999del5 (c.771_775del) carriers indicates an underlying biological explanation [29].